Catalog |
name |
Description |
price |
R-C-2701 |
GSK 525768A CAS:1260530-25-3 |
GSK 525768A is the enantiomer compound of GSK 525762A,which is a potent small molecule inhibitor that disrupt the function of the BET family of bromodomains (Brd2,Brd3,and Brd4);GSK 525768A has NO activity towards BET. |
price> |
R-C-2702 |
GSK1324726A (I-BET726) CAS:1300031-52-0 |
GSK1324726A is a novel,potent,and selective inhibitor of BET proteins with high affinity to BRD2(IC50=41nM),BRD3(IC50=31nM),and BRD4(IC50=22nM). |
price> |
R-C-2705 |
EPZ004777 CAS:1338466-77-5 |
EPZ004777 is a potent,selective DOT1L inhibitor with IC50 of 0.4nM in a cell-free assay and demonstrates>1,200-fold selectivity for DOT1L over all other tested PMTs.EPZ004777 induces apoptosis. |
price> |
R-C-2707 |
OG-L002 CAS:1357302-64-7 |
OG-L002 is a potent and highly selective LSD1 inhibitor with an IC50 of 0.02 μM.OG-L002 is a potent monoamine oxidases(MAO)inhibitor with IC50s of 1.38μM and 0.72μM for MAO-A and MAO-B,respectively.OG-L002 potently inhibits the expression of HSV IE genes. |
price> |
R-C-2708 |
CBB1003 CAS:1379573-88-2 |
CBB1003 is a novel histone demethylase LSD1 inhibitor with IC50 of 10.54uM. |
price> |
R-C-2709 |
CBB1007 CAS:1379573-92-8 |
CBB1007 is a cell-permeable amidino-guanidinium compound that acts as a potent,reversible and substrate competitive LSD1 selective inhibitor (IC50=5.27μM for hLSD1). |
price> |
R-C-2710 |
YM 750 CAS:138046-43-2 |
YM-750 is a potent acyl-CoA:cholesterol acyltransferase(ACAT)inhibitor(IC50=0.18 μM).ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A. |
price> |
R-C-2711 |
GSK J5 CAS:1394854-51-3 |
Inactive isomer of GSK J4;also cell permeable ester derivative of the inactive control,GSK J2. |
price> |